테바제약, 비용절감 기반 수익성 개선 기대…‘매수'-JP모건 - 마켓인
[unable to retrieve full-text content]
테바제약, 비용절감 기반 수익성 개선 기대…‘매수'-JP모건 마켓인2025-05-12 19:10:48Z
https://news.google.com/rss/articles/CBMic0FVX3lxTE5GbGVuajBmdks3N2E4bEpYQW95eWpvMkR5SmdkbUNoVXljeWJBOW1tYkNacm5fYmFPTVRlWEl0WllJTlVQakJMV1E0YUJ6VmN3NW1DM085R3AtS2NpZnBvdXF2dGhEWkd6MjItd3I5dzRHY3M?oc=5
CBMic0FVX3lxTE5GbGVuajBmdks3N2E4bEpYQW95eWpvMkR5SmdkbUNoVXljeWJBOW1tYkNacm5fYmFPTVRlWEl0WllJTlVQakJMV1E0YUJ6VmN3NW1DM085R3AtS2NpZnBvdXF2dGhEWkd6MjItd3I5dzRHY3M
Bagikan Berita Ini
0 Response to "테바제약, 비용절감 기반 수익성 개선 기대…‘매수'-JP모건 - 마켓인"
Posting Komentar